Line 2,583: |
Line 2,583: |
| |Astrocystoma, IDH-Mutant | | |Astrocystoma, IDH-Mutant |
| |Disease | | |Disease |
| + | |Riley Lochner (trainee), Shashi Shetty (mentor) |
| + | |3/3/2022 |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |Laveniya Satgunaseelan (LS) |
| | | | | |
− | | | + | |2021 template added |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
| |- | | |- |
− | |Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease|| | + | |Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor) |
− | | | + | |3/3/2022 |
− | |
| |
− | |
| |
− | |
| |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |Laveniya Satgunaseelan (LS) |
| | | | | |
| + | |2021 template added |
| |- | | |- |
| |Glioblastoma, IDH-Wildtype||Disease|| | | |Glioblastoma, IDH-Wildtype||Disease|| |
Line 2,646: |
Line 2,646: |
| | | | | |
| |- | | |- |
− | |Diffuse Midline Glioma, H3 K27-Altered||Disease|| | + | |Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version) |
− | |
| |
− | |
| |
− | |
| |
| | | | | |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |LS |
| | | | | |
| + | |2021 template added |
| |- | | |- |
− | |Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease|| | + | |Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu |
− | | | + | |2/21/2022 |
− | |
| |
− | |
| |
− | |
| |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |LS |
| | | | | |
| + | |2021 template added |
| |- | | |- |
− | |Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease|| | + | |Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova |
− | | | + | |10/28/2022 |
− | |
| |
− | |
| |
− | |
| |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |LS |
| | | | | |
| + | |2021 template added |
| |- | | |- |
| |Infant-Type Hemispheric Glioma||Disease|| | | |Infant-Type Hemispheric Glioma||Disease|| |
Line 2,680: |
Line 2,680: |
| | | | | |
| | | | | |
− | | | + | |2021 template added |
| |- | | |- |
− | |Pilocytic Astrocytoma||Disease|| | + | |Pilocytic Astrocytoma||Disease||Jeremy Pulvers |
− | | | + | |9/13/2022<br /> |
− | |
| |
− | |
| |
− | |
| |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |LS |
| | | | | |
| + | |2021 template added |
| |- | | |- |
| |High-Grade Astrocytoma with Piloid Features||Disease|| | | |High-Grade Astrocytoma with Piloid Features||Disease|| |
Line 2,736: |
Line 2,736: |
| | | | | |
| |- | | |- |
− | |Ganglioglioma||Disease|| | + | |Ganglioglioma||Disease||Leila Moayed-Aloei |
− | | | + | |6/30/2022 |
− | |
| |
− | |
| |
− | |
| |
| | | | | |
| + | |COMPLETE |
| | | | | |
| + | |LS |
| | | | | |
| + | |2021 template added |
| |- | | |- |
| |Gangliocytoma||Disease|| | | |Gangliocytoma||Disease|| |
Line 2,979: |
Line 2,979: |
| | | | | |
| |- | | |- |
− | |Medulloblastoma, WNT-Activated||Disease|| | + | |Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City |
− | | | + | |9/20/21 |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
| | | | | |
| + | |COMPLETE |
| | | | | |
| + | |Holli Drendel (interim)/Laveniya Satgunaseelan (LS) |
| + | |9/22/2022 |
| + | |2021 template added |
| |- | | |- |
| |Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease|| | | |Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease|| |